Yellow Fever Virus Vaccine Reduces T Cell Receptor Signaling and the Levels of Phosphatase PTPRE In Vivo
<strong>Background:</strong> A Src kinase-activating phosphatase (PTPRE) is targeted by a genome-derived yellow fever virus (YFV) short noncoding RNA (vsRNA) in vitro. The vsRNA reduces PTPRE translation, which leads to reduced TCR signaling. vsRNA point mutations restore PTPRE expressio...
Main Authors: | Jinhua Xiang, James H. McLinden, Qing Chang, Thomas M Kaufman, Judy A. Streit, Jack T. Stapleton |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Proceedings |
Subjects: | |
Online Access: | https://www.mdpi.com/2504-3900/50/1/97 |
Similar Items
-
Identification of a Novel Yellow Fever Virus Cellular Restriction Factor
by: Jinhua Xiang, et al.
Published: (2020-06-01) -
The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01) -
Yellow Fever—More a Policy and Planning Problem than a Biological One
by: Charles H. Calisher, et al.
Published: (2016-10-01) -
Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
by: Fredy Brice Simo Nemg, et al.
Published: (2022-04-01) -
What Constitutes Protective Immunity Following Yellow Fever Vaccination?
by: Jolynne Mokaya, et al.
Published: (2021-06-01)